NAFLD and Alcohol‐Associated Liver Disease Will Be Responsible for Almost All New Diagnoses of Cirrhosis in Canada by 2040
Jennifer A. Flemming, Maya Djerboua, Patti A. Groome, Christopher M. Booth, Norah A. Terrault – 25 June 2021
Splicing Factor SLU7 Prevents Oxidative Stress‐Mediated Hepatocyte Nuclear Factor 4α Degradation, Preserving Hepatic Differentiation and Protecting From Liver Damage
María Gárate‐Rascón, Miriam Recalde, Maddalen Jimenez, María Elizalde, María Azkona, Iker Uriarte, M. Uxue Latasa, Raquel Urtasun, Idoia Bilbao, Bruno Sangro, Carmen Garcia‐Ruiz, José C. Fernandez‐Checa, Fernando J Corrales, Argitxu Esquivel, Antonio Pineda‐Lucena, Maite G. Fernández‐Barrena, Matías A. Ávila, María Arechederra, Carmen Berasain – 24 June 2021
Donor Hepatic Occult Collagen Deposition Predisposes to Peritransplant Stress and Impacts Human Liver Transplantation
Hirofumi Hirao, Takahiro Ito, Kentaro Kadono, Hidenobu Kojima, Bita V. Naini, Kojiro Nakamura, Shoichi Kageyama, Ronald W. Busuttil, Jerzy W. Kupiec‐Weglinski, Fady M. Kaldas – 24 June 2021
Hepatic X‐Box Binding Protein 1 and Unfolded Protein Response Is Impaired in Weanling Mice With Resultant Hepatic Injury
Alyssa Kriegermeier, Angela Hyon, Meredith Sommars, Susan Hubchak, Brian LeCuyer, Xiaoying Liu, Grant Barish, Richard M. Green – 24 June 2021
Metabolic Complications in Liver Transplantation Recipients: How We Can Optimize Long‐Term Survival
Amirhossein Azhie, Priya Sheth, Ahmed Hammad, Minna Woo, Mamatha Bhat – 23 June 2021 – Liver transplantation (LT) recipients have experienced a significant improvement in short‐term survival during the past 3 decades attributed to advancements in surgical techniques, perioperative management, and effective immunosuppressive regimens. However, long‐term survival is affected by a high incidence of metabolic disorders and their consequences, including cardiovascular disease (CVD) and malignancies.
Letter to the Editor: High Mobility Group Box Protein 1 Release Is an Identified Driver of Inflammation in the Pathogenesis of Biliary Atresia
Shaojun Shi, Sunrui Chen, Monique M.A. Verstegen, Qiuwei Pan, Luc J.W. Laan – 22 June 2021
Allograft Fibrosis After Pediatric Liver Transplantation: Incidence, Risk Factors, and Evolution
Roberta Angelico, Marco Spada, Daniela Liccardo, Domiziana Pedini, Chiara Grimaldi, Andrea Pietrobattista, Maria Sole Basso, Claudia Della Corte, Antonella Mosca, Maria Cristina Saffioti, Rita Alaggio, Giuseppe Maggiore, Manila Candusso, Paola Francalanci – 22 June 2021 – Allograft fibrosis (AF) after pediatric liver transplantation (pLT) is frequent, but its dynamics are unclear. Our aim was to assess the evolution and risk factors of AF after pLT.
On the Mechanisms of Biliary Flux
Nachiket Vartak, Dirk Drasdo, Fabian Geisler, Tohru Itoh, Ronald P.J.Oude Elferink, Stan F.J. Graaf, John Chiang, Verena Keitel, Michael Trauner, Peter Jansen, Jan G. Hengstler – 22 June 2021 – Since the late 1950s, transport of bile in the liver has been described by the “osmotic concept,” according to which bile flows into the canaliculi toward the ducts, countercurrent to the blood flow in the sinusoids. However, because of the small size of canaliculi, it was so far impossible to observe, let alone to quantify this process.
Mast Cells Regulate Ductular Reaction and Intestinal Inflammation in Cholestasis Through Farnesoid X Receptor Signaling
Vik Meadows, Lindsey Kennedy, Burcin Ekser, Konstantina Kyritsi, Debjyoti Kundu, Tianhao Zhou, Lixian Chen, Linh Pham, Nan Wu, Jennifer Demieville, Laura Hargrove, Shannon Glaser, Gianfranco Alpini, Heather Francis – 22 June 2021